Brello vs Orderly Health: GLP-1 Medications and Pricing

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management, and the genetics behind every metabolic decision. Browse all Peptides & GLP-1 education.

Independent editorial review. PlexusDx has no commercial relationship with Brello or Orderly Health, uses no affiliate links, and received no compensation for it.

Search "Brello vs Orderly meds" and the interest is squarely on the medications: which forms each program dispenses, how they reach you, and what actually differs when the molecule is the same. This piece keeps the lens on the drugs and dispensing as of April 2026, with a fair-balance frame.

Two routes to the same medications

Brello and Orderly Health both connect patients to GLP-1 therapy through telehealth, but a program is a delivery route, not a manufacturer. Understanding the "meds" means separating what is intrinsic to the compound from what is a feature of the platform — shipping cadence, product form, and dispensing pathway.

Orderly Health's dispensing model

Orderly Health (Orderly) operates telehealth combined with compounded pharmacy. Program structure, medication options, and pricing vary, so consult Orderly Health's official website for current details when you read this. Eligible patients receive prescriptions filled as branded products or compounded semaglutide or tirzepatide through a licensed pharmacy.

Brello's dispensing model

Brello (Brello Health) uses the same telehealth-plus-compounding structure. A licensed provider evaluates the patient, and prescriptions are fulfilled as branded FDA-approved GLP-1 products or compounded semaglutide or tirzepatide via a 503A pathway. Check Brello's own site for its current medication menu and terms.

Medication forms and how they reach you

Within this category, GLP-1 therapy commonly comes as an injectable or, in some programs, an oral formulation, shipped directly to the patient after clinician review. The specific form, supply interval, and titration support differ by brand and by whether the product is branded or compounded. Confirm what each program actually ships before committing.

The pricing picture

Monthly totals across GLP-1 telehealth ran roughly $200 to $700 or more in April 2026, reflecting program fees, the medication itself, and compounded dispensing where applicable. Neither brand's figure is fixed. Verify current pricing at each company's own page rather than relying on numbers quoted secondhand.

Why the compound, not the platform, drives results

The pharmacology is fixed regardless of who ships it. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide modulate appetite and satiety identically, and the trial record — STEP (NEJM, 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024) — belongs to the molecule.

Supply continuity and refills

For a medication taken over months, continuity matters as much as the first fill. Refill timing, how a program handles back-orders, and whether your dose can be adjusted without restarting the process all shape the real experience. Confirm how Brello and Orderly manage ongoing supply, because a gap between shipments can undo weeks of steady progress.

The genetic map neither draws

Both programs dispense without charting your metabolic baseline. FTO, the fat-mass and obesity-associated gene, joins GLP1R, MC4R, and TCF7L2 as pathway-level markers of the terrain a clinician prescribes into. They describe biology, not drug response. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights. PlexusDx also dispenses the compounds through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — and the test does not predict response to any specific medication.

Independence note: PlexusDx is not affiliated with Brello or Orderly Health; this review is education only.

More reading: GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs, and GLP 1 Hormone.

Editorial disclaimer: This comparison is educational. PlexusDx has no tie to Brello or Orderly Health but sells semaglutide and tirzepatide through its own protocols, so treat it as a disclosed viewpoint. The Precision Peptide Genetic Test maps gene-pathway influences and does not predict medication response. Consult a qualified provider before starting any protocol.

Compare the medications directly: view the PlexusDx Weight Management Protocols, or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

Do Brello and Orderly offer injectable or oral GLP-1 meds?

Both operate in a category where GLP-1 therapy is usually injectable, with oral formulations available in some programs. The specific forms depend on the brand and on whether the product is branded or compounded. Confirm exactly which forms each program ships before you enroll.

Are the compounded medications the same as branded GLP-1?

Compounded semaglutide or tirzepatide is prepared by a licensed pharmacy under a prescription and is not an FDA-approved finished drug, though it works within the same class. A prescriber judges suitability. Verify the dispensing pathway each program uses so you know what you are receiving.

Does the platform change how the medication works?

No. The pharmacology is a property of the compound, not the telehealth brand delivering it. Brello, Orderly, and others differ in shipping, support, and price, not in the drug's action. Genetics like FTO describe your baseline but never predict a specific medication's effect.

Continue learning at the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.